SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: •Location:https://investor.resmed.com •Date:Thursday, ...

ResMed (RMD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing earnings picture ...

Anand Chokkavelu, CFA has no position in any of the stocks mentioned. Emily Flippen, CFA has no position in any of the stocks mentioned. Jason Moser has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ResMed. The Motley Fool has a disclosure policy. ...

公司评价 - ResMed Inc 被列为极少数值得长期持有的公司之一 [1] 分析师持仓 - 分析师持有 ResMed Inc 的多头头寸 包括股票 期权或其他衍生品 [2]

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style S ...

A month has gone by since the last earnings report for ResMed (RMD) . Shares have added about 4% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is ResMed due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It turns out, estimat ...

ResMed Inc.’s (RMD) growth in the third quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its progress in digital health technology continues to drive overall revenue growth. However, a dull macroeconomic scenario and fierce competition put pressure on ResMed’s operations. In the past year, shares of this Zacks Rank #3 (Buy) company have surged 15.1%, outperforming the industry’s 8.6% growth and the S&P 500 composite’s 10.1% rise.The renowned medical device company has ...

文章核心观点 - Resmed成为卡塔尔航空英国和爱尔兰狮队澳大利亚巡回赛的官方睡眠合作伙伴，将开展活动提升人们对睡眠重要性的认识 [1][3] 分组1：巡回赛介绍 - 巡回赛为期六周，狮队将与澳大利亚队、超级橄榄球太平洋球队和表演队在澳大利亚六个城市进行比赛，预计有4万名球迷随行 [2] - 英国和爱尔兰狮队共进行10场比赛，其中包括三场与澳大利亚队的测试赛，分别在布里斯班、墨尔本和悉尼举行 [8] - 英国和爱尔兰狮队每四年前往南半球与澳大利亚、新西兰或南非进行具有里程碑意义的巡回赛，2027年将举办首届女子巡回赛前往新西兰与世界冠军比赛 [9][10] 分组2：Resmed合作举措 - Resmed作为官方睡眠合作伙伴，将推出以传奇橄榄球运动员为特色的“Tackle Your Sleep”数字和内容宣传活动，提升球员和球迷对优质睡眠重要性的认识 [3] 分组3：睡眠问题及影响 - 睡眠不足会对身心健康、人际关系和日常表现造成严重影响，对运动员而言会影响训练、动力、身体表现并增加受伤风险 [4] - 一项对175名橄榄球和板球运动员的研究发现，一半人被归类为睡眠不佳者，许多人报告有明显的日间疲劳 [4] - Resmed 2025年全球睡眠调查发现，全球四分之一的人选择忍受睡眠不佳的状况 [5] 分组4：各方观点 - Resmed首席营销官表示睡眠影响生活各方面，但可采取措施改善睡眠健康，作为合作伙伴很高兴提升人们对睡眠与运动表现关系的认识 [5][6] - 英国和爱尔兰狮队首席执行官称睡眠是表现的重要组成部分，Resmed为适应和恢复策略增添新维度，也会帮助球迷保持良好休息 [6][7] - 澳大利亚橄榄球首席执行官表示Resmed是行业领导者，欢迎其成为巡回赛官方合作伙伴，优质睡眠对球员和球迷都很重要 [7][8] 分组5：公司介绍 - Resmed是一家健康科技公司，致力于创造改变生活的健康技术，通过人工智能数字健康解决方案、云连接设备和智能软件让家庭医疗更个性化、可及和有效 [13]

文章核心观点 - Resmed收购VirtuOx支持其在虚拟护理领域的增长，扩大诊断途径，提升患者和医疗服务提供者的数字体验，体现其改善医疗服务方式的承诺 [1][2] 收购情况 - 2025年5月1日Resmed宣布收购VirtuOx，VirtuOx是睡眠、呼吸和心脏疾病的领先独立诊断测试机构 [1] - 交易完成后VirtuOx将作为Resmed的全资子公司运营，短期内继续以现有品牌为合作伙伴和患者服务，其领导团队将留任并推动公司增长和创新战略 [6] - 未披露财务条款，此次收购对Resmed财务结果无重大影响 [6] 收购意义 - 收购体现Resmed改善医疗服务方式的承诺，使其能更早支持患者，帮助医疗服务提供者和家庭护理公司以更简单、更互联的方式提供护理 [2] - VirtuOx虚拟测试平台可降低诊断障碍，为患者提供快速、灵活且经济实惠的选择，尤其针对睡眠呼吸障碍等常被漏诊的疾病 [3] - 整合VirtuOx诊断能力可加速评估与治疗之间的时间，减少患者流失，让更多人获得睡眠呼吸暂停及相关疾病治疗的益处 [4] - 收购加强Resmed与医疗服务提供者合作，简化诊断流程，缓解当前瓶颈，扩大与家庭医疗设备供应商的合作，支持患者开始治疗，还能为医疗服务提供者提供集成工具，改善护理协调、患者参与度和治疗效果 [4] - 收购支持家庭护理需求增长，创造拓展至失眠等相邻领域的机会，加深Resmed与医生、睡眠实验室和家庭医疗设备供应商的关系 [5] 公司介绍 - Resmed是专注于睡眠、呼吸和家庭护理的领先健康科技公司，其AI数字健康解决方案等使家庭医疗更个性化、可及和有效，愿景是让人们通过更好的睡眠和呼吸发挥全部潜力 [7] - VirtuOx是软件支持的独立诊断测试机构，为美国各地的睡眠、呼吸、心脏等健康状况提供家庭和远程测试服务 [8]

All three major stock indices of Wall Street ended in the green on April 24, primarily boosted by better-than-expected earnings anticipation from a handful of tech biggies, including Alphabet and Intel. This came as a momentary relief for investors, considering that U.S. President Trump’s tariff announcements had created quite a stir in the global stock market in recent weeks. The general market consensus is that investors still expect volatility to prevail on Wall Street, which makes them extra cautious wh ...